As of 3:10pm ET
| -0.005 / -0.79%|
The 3 analysts offering 12-month price forecasts for Aviragen Therapeutics Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 2.50. The median estimate represents a +693.65% increase from the last price of 0.63.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.